ORTHOPEDIATRICS CORP Gross Profit

Quick Answer

ORTHOPEDIATRICS CORP reported Gross Profit of $172.66 million for fiscal year 2025.

ORTHOPEDIATRICS CORP Gross Profit — Annual History

Fiscal Year Gross Profit YoY Change
2025 $172.66M +16.2%
2024 $148.60M +33.6%
2023 $111.25M +22.7%
2022 $90.66M +23.5%
2021 $73.40M +33.4%
2020 $55.03M +0.8%
2019 $54.62M +28.0%
2018 $42.68M +23.9%
2017 $34.45M +30.7%
2016 $26.37M +21.9%
2015 $21.64M

Quarterly Gross Profit

Quarter Ending Gross Profit YoY QoQ
September 30, 2025 $45.27M +13.0% +2.9%
June 30, 2025 $44.02M +7.9% +15.0%
March 31, 2025 $38.26M +18.9% -4.5%
September 30, 2024 $40.06M +29.4% -1.8%
June 30, 2024 $40.80M +35.9% +26.8%
March 31, 2024 $32.17M +36.6% +3.9%
September 30, 2023 $30.95M +19.6% +3.1%
June 30, 2023 $30.02M +20.2% +27.4%
  • ORTHOPEDIATRICS CORP showed an increase of +16.2% in Gross Profit compared to the prior fiscal year.
  • Over the 2015–2025 period, ORTHOPEDIATRICS CORP’s gross profit has grown by 698.0% (from $21.64 million to $172.66 million).
  • The most recent figure is from ORTHOPEDIATRICS CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment